NEUMORA THERAPEUTICS INC.
NMRA·640979100·US·Common Stock·Healthcare - Biotechnology-Activist
NMRA (NEUMORA THERAPEUTICS INC.) is held by 65 institutional investors as of Q1 2026. Largest holders: SOFTBANK GROUP CORP. ($11.9M), VANGUARD CAPITAL MANAGEMENT LLC ($7.6M), FMR LLC ($6.8M). Net institutional sentiment: Mixed.
65
Holders
Avg rating(10 Elite)
$77.3M
Total Value
60% (70)
Fund Consensus
38 buying - 25 selling
Who's Trading
ActivistKHK2 HealthVentures Equity Trust LLC3.1%May 15, 2026
ActivistRDRaymond Debbane4.7%May 4, 2026
ActivistAVARCH Venture Fund VII, L.P.18.6%Apr 1, 2026
InsiderBLBERNS PAUL LSell $34KFeb 17, 2026
InsiderASAurora Daljit SinghSell $22KFeb 17, 2026
InsiderPJPinto JoshuaSell $21KFeb 17, 2026
InsiderMLMilligan Michael LeeSell $5KFeb 17, 2026
InsiderASAurora Daljit SinghSell $307KNov 11, 2025
InsiderALARCH Venture Partners XII, LLCBuy $5.0MOct 27, 2025
InsiderALARCH Venture Partners X, LLCBuy $5.0MOct 27, 2025
13F: Insider & Congress:
Showing 1-20 of 70
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer